The IMPACT study is an international multi-centre retrospective study of patients with an incidental intracranial meningioma. The primary aim of the study will be to externally validate and calibrate a prognostic model of radiological and clinical progression – IMPACT (Incidental Meningioma: Prognostic Analysis Using Patient Comorbidity and MRI Tests) https://www.impact-meningioma.com.  

The study will include patients with an incidental intracranial meningioma diagnosed between 01/01/2009 and 31/12/2010. Data will be recorded until death or last date of follow-up.

 

The study began in September 2020

 

Study lead: Abed Islim